Drug Profile
H 34552
Alternative Names: H 345Latest Information Update: 07 Feb 2003
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Class III antiarrhythmics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias